Results 81 to 90 of about 265,487 (267)

Clinical periodontal diagnosis

Periodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi, Andrea Roccuzzo, Jean‐Claude Imber, Alexandra Stähli, Björn Klinge, Niklaus P. Lang   +5 more
wiley   +1 more source

Fiscal Year 2018

, 2018
Annual financial report of the Texas Council on Alzheimers's Disease and Related Disorders documenting income, expenditures, and other relevant financial information for fiscal year ...
Texas Council on Alzheimer's Disease & Related Disorders
core  

Impulsivity spectrum disorders as a risk factor for cocaine-induced psychosis

, 2011
IntroductionChronic consumption of cocaine can induce transient psychotic symptoms, expressed as paranoia or hallucinations. This is typically prevented by abstinence.
N. Martínez-Luna, C. Roncero, L. Miquel, C. Miguel, S. Gómez-Baeza, L. Grau-López, C. Daigre, M. Comin, M. Artiaga, C. Rodriguez-Dominguez   +9 more
core   +1 more source

From Conflicting Outcomes to Mutual Losses: How Punitive Responses to Problematic Substance Use Suppress Help‐Seeking and Cause Harm

Human Resource Management Journal, EarlyView.
ABSTRACT Problematic substance use (PSU) is a significant, inadequately managed people management challenge. Drawing on the conflicting outcomes and mutual losses perspectives on HRM and employee wellbeing, and using Job Demands‐Resources theory to explain underlying strain‐driven loss cycles, we examine factors shaping PSU and help‐seeking among 575 ...
Karen Maher, Aoife M. McDermott, Andrew Clements, Emmert Roberts, Sally Pezaro   +4 more
wiley   +1 more source

Family Aggregation and Risk Factors in Phobic Disorders over Three-Generations in a Nation-Wide Study [PDF]

, 2016
OBJECTIVE This nation-wide register-based study investigated how often phobic disorders (PHO) and co-morbid disorders occur in affected families compared to control families.
Jakobsen, Helle, Roselind Lieb, Andrea Meyer, Steinhausen, Hans-Christoph, Helle Jakobsen, Meyer, Andrea, Lieb, Roselind, Jørgensen, Povl Munk, Povl Munk Jørgensen, Hans-Christoph Steinhausen   +9 more
core   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Kappa Opioid Regulation of Stress-Related Behavior

, 2010
Anxiety disorders affect roughly 40 million American adults in a given year. Those suffering from anxiety disorders often experience additional stress-linked illnesses, such as depression.
Harshberger, Erin
core  

Impulsivity traits in patients with multiple sclerosis

, 2020
Background Multiple sclerosis (MS) is a demyelinating disease with a lifetime prevalence of 4.41/100000 in Bogota, Colombia. It is known that it can be related with neuropsychiatric disorders, increasing by a factor of three the prevalence of depression
Duque, Alejandra, Toro, Jaime, Cuéllar-Giraldo, David Felipe, Patiño, Jorge, Díaz, Camilo, Orozco-Cabal, Luis Felipe, Cortés, Fabián, Blanco, Luisa, Burbano, Lisseth, Reyes, Saúl   +9 more
core   +1 more source

Testing Genetic and Environmental Associations Between Personality Disorders and Cocaine Use: A Population-Based Twin Study [PDF]

, 2018
Until now, data have not been available to elucidate the genetic and environmental sources of comorbidity between all 10 DSM-IV personality disorders (PDs) and cocaine use.
Ystrøm, Eivind, Ragnar Nesvåg, Ted Reichborn-Kjennerud, South, Susan Carol, Torvik, Fartein Ask, Gillespie, Nathan A., Kenneth S. Kendler, Gentry, Amanda E., Nesvåg, Ragnar, Susan C. South, Nathan A. Gillespie, Michael C. Neale, Steven H. Aggen, Fartein A. Torvik, Kendler, Kenneth Seedman, Tom H. Rosenström, Robert F. Krueger, Czajkowski, Nikolai Olavi, Krueger, Robert Frederick, Knudsen, Gun Peggy S., Nikolai Czajkowski, Eivind Ystrom, Aggen, Steven H., Reichborn-Kjennerud, Ted, Gun P. Knudsen, Amanda E. Gentry, Rosenström, Tom Henrik, Neale, Michael Churton   +27 more
core   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source